 |
Sard Verbinnen & Co. represents Cue Health as the San Diego health technology company and maker of home test kits for COVID-19 readies an initial public offering.
The company's goal is to enable people to manage their health through real-time, actionable and connected health data.
Cue envisions a suite of testing kits to provide consumers lab-quality results in 20 minutes without the need to visit a medical facility.
It is working on test kits for influenza, respiratory syncytial virus, fertility, pregnancy and inflammation. Cue plans to file for FDA approval for those kits during the second half of next year.
The company signed a $480M agreement with the Pentagon and Dept of Health and Human Services in Oct. 2020 for 6M of its test kits.
The National Basketball Assn. counted on the Cue COVID-19 test during its 2020 “bubble season.”
Cue posted $201M in first-half revenues and earned $32.8M.
It plans to list its stock on the NASDAQ.
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to get acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Teneo represents Honeywell spin-off Solstice Advanced Materials as it buys Collected Strategies client Element Solutions in a deal pegged at $14.5B.
Dallas-based Throughline Global Advisors advised Principal Mineral as it acquired Isola Group, maker of copper-clad laminates used in printed circuit boards.
oele Frank works for satellite operator Iridium Communications as it gets acquired by space company Rocket Lab in a deal worth $8B.
Uber’s Mike Lucarelli is moving to NXP Semiconductors as senior VP-investor relations.
